Controversies in Candida management.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ijantimicag.2015.10.008PMID 26627934
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.

  2017cited by this paper
• Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008).

  2015cited by this paper
• Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

  2015cited by this paper
• Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.

  2014cited by this paper
• Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*

  2014cited by this paper
• Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

  2014cited by this paper
• MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

  2014cited by this paper
• What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients

  2014influential reference
• Update on antifungal resistance in Aspergillus and Candida.

  2014cited by this paper
• Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.

  2014cited by this paper
• Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain

  2013cited by this paper
• Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

  2013cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

  2012cited by this paper
• Pharmacotherapy approaches to antifungal prophylaxis

  2012cited by this paper
• Septic shock attributed to Candida infection: importance of empiric therapy and source control.

  2012cited by this paper
• Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

  2012cited by this paper
• Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

  2011cited by this paper
• Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials.

  2010cited by this paper
• Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial

  2009cited by this paper
• Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment

  2009cited by this paper
• Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.

  2009influential reference
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009influential reference
• Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.

  2009cited by this paper
• Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

  2008cited by this paper
• Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

  2008cited by this paper
• Empirical Fluconazole versus Placebo for Intensive Care Unit Patients

  2008cited by this paper
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007cited by this paper
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

  2007cited by this paper
• Comparative evaluation of (1, 3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia

  2007cited by this paper
• Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.

  2007cited by this paper
• Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

  2007cited by this paper
• Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.

  2006cited by this paper
• A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*

  2006cited by this paper
• Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

  2005cited by this paper
• Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?*

  2003cited by this paper
• Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

  2002cited by this paper
• In Vitro Pharmacodynamic Properties of Three Antifungal Agents against Preformed Candida albicans Biofilms Determined by Time-Kill Studies

  2002cited by this paper
• Trends in species causing fungaemia in a tertiary care medical centre over 12 years

  2001cited by this paper
• Candida Colonization and Subsequent Infections in Critically III Surgical Patients

  1994cited by this paper
• IDSA GUIDELINES Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

  year unknowncited by this paper

• Unresolved issues in the diagnosis of catheter related candidemia: A position paper

  2023cites this paper
• The Utility of EQUAL Candida Score in Predicting Mortality in Patients with Candidemia

  2022cites this paper
• Predominance of Candida Glabrata among Non-albicans Candida Species in a 16-Year Study of Candidemia at a Tertiary Care Center in Lebanon

  2021cites this paper
• Impact of Antimicrobial Prophylaxis for Severe Acute Pancreatitis on the Development of Invasive Candidiasis: A Large Retrospective Multicenter Cohort Study

  2019cites this paper
• Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship

  2018cites this paper
• Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the fks Mutants

  2017cites this paper
• Auf Pilzsuche in der Lunge

  2017cites this paper
• Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species

  2017cites this paper